Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
15,882
Total Claims
$2.3M
Drug Cost
1,084
Beneficiaries
$2,142
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+52%
Cost per patient vs peers
$2,142 vs $1,411 avg
+52%
Brand preference vs peers
16.2% vs 10.6% avg
Brand vs Generic
Brand: 2,531 claims · $1.9M
Generic: 13,087 claims · $406K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Diclofenac Epolamine | 453 | $335K |
| Sitagliptin Phosphate | 197 | $238K |
| Dapagliflozin Propanediol | 173 | $213K |
| Empagliflozin | 130 | $185K |
| Icosapent Ethyl | 191 | $128K |
| Semaglutide | 59 | $123K |
| Tenofovir Alafenamide | 53 | $103K |
| Linagliptin | 71 | $83K |
| Denosumab | 22 | $37K |
| Apixaban | 49 | $36K |
| Sitagliptin Phos/Metformin Hcl | 27 | $34K |
| Fluticasone/Umeclidin/Vilanter | 44 | $33K |
| Rivaroxaban | 30 | $29K |
| Budesonide/Formoterol Fumarate | 53 | $24K |
| Budesonide/Glycopyr/Formoterol | 25 | $21K |
Prescribing Profile
Patient Profile
74
Avg Age
53%
Female
1.10
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data